Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores

被引：0
|
作者：
Sazuka, Tomokazu [1 ]
Arai, Takayuki [1 ]
Sato, Hiroaki [1 ]
Goto, Yusuke [1 ]
Sakamoto, Shinichi [1 ]
Ichikawa, Tomohiko [1 ]
机构：
[1] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2023年 / 30卷 / 11期
关键词：
D O I：
10.1111/iju.15249
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1054 / 1056
页数：3
相关论文
共 50 条
  • [31] Treatment sequence after first-line nivolumab plus ipilimumab or sunitinib monotherapy in patients with metastatic renal cell carcinoma (mRCC) using real-world data.
    Geynisman, Daniel M.
    Faccone, Jillian
    Zhang Ying
    Ejzykowicz, Flavia
    Stwalley, Brian
    Hamilton, Melissa
    Le, Trong Kim
    Huo, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [32] Real-world short-term outcomes and treatment regimen comparisons in patients with metastatic renal cell carcinoma treated with first-line immune combinations
    Kikuta, Masato
    Naito, Sei
    Osawa, Takahiro
    Numakura, Kazuyuki
    Narisawa, Takafumi
    Takai, Yuki
    Yagi, Mayu
    Sekine, Yuya
    Tokairin, Ojiro
    Shinohara, Nobuo
    Habuchi, Tomonori
    Tsuchiya, Norihiko
    BMC CANCER, 2025, 25 (01)
  • [33] Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan
    Miyazaki, Akira
    Miyake, Hideaki
    Harada, Ken-ichi
    Inoue, Taka-Aki
    Fujisawa, Masato
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 601 - 606
  • [34] EVALUATING REAL-WORLD HEALTH-RELATED QUALITY OF LIFE IN A SURVEY OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA RECEIVING FIRST-LINE TREATMENT IN THE US
    Zanotti, G.
    Ribbands, A.
    Leith, A.
    Forshaw, C.
    Middleton-Dalby, C.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S217 - S217
  • [35] Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first-line immunotherapy containing combinations in all IMDC groups?
    McGrane, John
    Frazer, Ricky
    Challapalli, Amarnath
    Ratnayake, Gihan
    Boh, Zhaung
    Clayton, Alison
    Chau, Caroline
    Sharma, Anand
    Elgendy, Manal
    Charnley, Natalie
    Mohamed, Wael
    Kingdon, Sarah
    Protheroe, Andrew
    Lydon, Anna
    Halstead, Anna
    Ford, Vicky
    Muazzam, Iqtedar
    Lee, Dawn
    Melendez-Torres, G. J.
    Bahl, Amit
    CANCER MEDICINE, 2024, 13 (12):
  • [36] Treatment patterns and clinical outcomes in pazopanib compared to sunitinib as first-line therapy for patients with advanced/metastatic renal cell carcinoma (aRCC) in a US community oncology setting
    Hirsch, Bradford W.
    Wilson, Thomas
    Ghate, Sameer
    Perez, Jose
    Vogelzang, Nicholas
    BJU INTERNATIONAL, 2016, 118 : 23 - 23
  • [37] TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PAZOPANIB COMPARED WITH SUNITINIB AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED/METASTATIC RENAL CELL CARCINOMA IN A COMUNITY ONCOLOGY SETTING IN THE UNITED STATES
    Hirsch, B.
    Jiao, X.
    Wilson, T.
    Ghate, S. R.
    Hackshaw, M.
    Perez, J. R.
    Vogelzang, N.
    VALUE IN HEALTH, 2016, 19 (03) : A140 - A140
  • [38] Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments
    De Groot, S.
    Blommestein, H. M.
    Redekop, W. K.
    Sleijfer, S.
    Kiemeney, L. A. L. M.
    Oosterwijk, E.
    Uyl-de Groot, C. A.
    PLOS ONE, 2017, 12 (05):
  • [39] Impact of number of treatment lines following first-line (1L) immuno-oncology (IO) combination on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).
    Lemelin, Audreylie
    Ernst, Matthew Scott
    Wells, Connor
    Navani, Vishal
    McGregor, Bradley Alexander
    Wong, Shirley S.
    Pal, Sumanta Monty
    Basappa, Naveen S.
    Kapoor, Anil
    Lee, Jae-Lyun
    Donskov, Frede
    Li, Haoran
    Yuasa, Takeshi
    Chang, Rose
    Huynh, Lynn
    Nguyen, Catherine
    Holub, Ashley
    Clear, Louise
    Duh, Mei Sheng
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [40] Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients
    Shani Shrem, Noa
    Beltran-Bless, Ana-Alicia
    Ghosh, Sunita
    Tajzler, Camilla
    Wood, Lori A.
    Kollmannsberger, Christian
    Basappa, Naveen S.
    Graham, Jeffrey
    Fallah-Rad, Nazanin
    Heng, Daniel Y. C.
    Soulieres, Denis
    Lalani, Aly-Khan A.
    Breau, Rodney H.
    Finelli, Antonio
    Tanguay, Simon
    Bhindi, Bimal
    Bjarnason, Georg
    Pouliot, Frederic
    Canil, Christina
    CANCERS, 2025, 17 (03)
12345